Position in OCGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$53,785
+$23,716 QoQ
Shares Held
29,716
+33.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mariner, LLC holds $292,530,938 across 135 Biotechnology names. OCGN ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
123,954 | $95,771,818 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,600 | $58,764,664 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
268,901 | $15,190,217 | |
| 4 | EXEL |
Exelixis, Inc.
|
307,928 | $13,207,031 | |
| 5 | INCY |
Incyte Corp
|
121,091 | $11,397,084 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,948 | $9,908,894 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
40,016 | $7,565,024 | |
| 8 | RPRX |
Royalty Pharma plc
|
130,656 | $6,267,568 |
All Filings in OCGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,785 | 29,716 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,069 | 22,274 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,368 | 22,312 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,598 | 22,266 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,444 | 19,043 | Shares | Sole | 2025-05-15 | |
| 2023-09-30 | $11,841 | 29,605 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $18,111 | 10,175 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||